HomeACAD • NASDAQ
add
ACADIA Pharmaceuticals Inc
Previous close
$17.07
Day range
$16.62 - $17.30
Year range
$16.60 - $33.99
Market cap
2.75B USD
Avg Volume
1.85M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 231.04M | 69.27% |
Operating expense | 111.46M | 6.77% |
Net income | 45.80M | 209.76% |
Net profit margin | 19.82 | 164.83% |
Earnings per share | 0.28 | 207.69% |
EBITDA | 36.58M | 180.27% |
Effective tax rate | -15.35% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 438.86M | 5.29% |
Total assets | 748.96M | 27.41% |
Total liabilities | 317.20M | 69.27% |
Total equity | 431.76M | — |
Shares outstanding | 164.77M | — |
Price to book | 6.52 | — |
Return on assets | 12.65% | — |
Return on capital | 19.24% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 45.80M | 209.76% |
Cash from operations | 85.39M | 457.97% |
Cash from investing | -347.00K | 98.04% |
Cash from financing | 5.43M | 236.68% |
Net change in cash | 90.46M | 326.18% |
Free cash flow | 61.77M | 659.41% |
About
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California. Wikipedia
Founded
1993
Headquarters
Website
Employees
598